Discordance between eGFRcystatin C and eGFRcreatinine and cardiovascular risk in the FLOW trial
Authors:
Inga Soveri1; Johannes F.E. Mann2; Richard Pratley3; Roland E. Schmieder4; David Cherney5; Richard MacIsaac6; Peter Rossing7; Kenneth W. Mahaffey8; L. Sreenivasamurthy9; Srikanth Bellary10,11, Vlado Perkovic12; Soo Kun Lim13; Janusz Gumprecht14; Nicolas Belmar15; Heidrun Bosch-Traberg15; Søren Rasmussen15; Katherine Tuttle16,17; David M. Charytan18